|
시장보고서
상품코드
1424018
세계 gRNA 시장 : 점유율, 규모, 동향, 산업 분석 보고서 - 제품 및 서비스별, gRNA 유형별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024년-2032년)gRNA Market Share, Size, Trends, Industry Analysis Report, By Product & Services (Products, Custom gRNA Synthesis Services), By gRNA Type, By Application, By End-use, By Region, And Segment Forecast, 2024 - 2032 |
||||||
Polaris Market Research의 최신 조사에 따르면 세계 gRNA 시장 규모는 2032년까지 23억 5,717만 달러에 이를 것으로 예상됩니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.
이 시장은 바이오 테크놀로지 기업과 제약 기업에 의한 R&D 활동에 대한 투자가 증가함에 따라 향후 성장이 예상되고 있습니다. 사용자 친화적이고 비용 효율적인 gRNA 합성 키트 및 서비스의 출현으로 CRISPR-Cas9 기술에 대한 액세스가 민주화되어 다양한 전문 수준의 연구자를 수용할 수 있게 되었습니다. CRISPR-Cas9의 새로운 애플리케이션의 지속적인 탐구는 gRNA의 지속적인 수요에 기여합니다.
NGS의 채용 증가는 시장 성장의 중요한 촉임베디드니다. NGS 기술의 보급으로 연구원은 게놈 분석 및 조작을 위한 고급 도구를 얻을 수 있습니다. NGS는 높은 처리량에서 효율적인 유전자 시퀀싱을 가능하게 하며 전체 게놈을 조사하는 빠르고 비용 효율적인 수단을 제공합니다. 이 효율성은 유전자 조작을 위한 표적 유전자의 동정과 검증을 간소화하는 gRNA 응용에 특히 중요합니다. 이 정확도는 CRISPR/ Cas 시스템을 사용하여 특이성이 높은 gRNA를 만드는 데 필수적입니다.
또한, 새로운 최종 gRNA 제품의 소개는 혁신을 자극할 잠재력을 가지고 있습니다. 예를 들어(2023년) 10월에는 IND 가능한 gRNA를 제공하는 Synthego사가 등장합니다. 이 획기적인 제품은 GLP로 규제된 전임상시험이나 IND 취득을 가능하게 하는 연구에 맞춘 면밀하게 설계된 고품질의 gRNA를 연구자에게 제공함으로써 CRISPR 기반 세포, 유전자 치료 전 임상 파이프라인의 큰 진보를 의미합니다.
생산량을 확대하는 것은 어렵고 적절한 시약, 재료 및 장비에 대한 접근으로 제약을 받을 수 있습니다. 치료가 자기 유래인지 동종인지에 관계없이, 중요한 과제는 수작업에서 상업적으로 자동화된 제조로의 전환에 있습니다. 이 전환은 모든 프로세스를 통해 균일성을 달성하고 규제를 확실하게 준수해야 합니다. 예를 들어, 세포 및 유전자 치료에 있어서의 바이러스 벡터의 부족율은 500%를 초과하는 것으로 추정되고 있습니다.
gRNA 시장 보고서 하이라이트
주로 진행 중인 임상시험과 분자연구목적에 따라 연구 용도 부문이 시장을 독점하고 있습니다.
게놈과 단백질체학의 발전으로 게놈 공학 분야가 가장 큰 점유율을 차지
개인화 치료에 gRNA를 채택하여 제약 회사가 최대 점유율을 획득
아시아태평양은 주로 암메트 메디컬 니즈의 존재와 이 분야의 기술 혁신에 의해 급성장할 것으로 보입니다.
시장 진출기업에는 Agilent Technologies, Horizon Discovery, Jena Bioscience, Merck, Synbio Technologies, Synthego, Takara Bio Inc. 등이 포함됩니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계 gRNA 시장에 대한 인사이트
- gRNA-산업 스냅샷
- gRNA 시장 역학
- 성장 촉진요인과 기회
- 단백질체학와 유전체학에서의 혁신
- 맞춤 치료의 필요성 증가
- 억제요인과 과제
- 확장성과 용량 부족으로 성장이 제한된다
- 성장 촉진요인과 기회
- PESTLE 분석
- gRNA 업계 동향
- 밸류체인 분석
- COVID-19 감염의 영향 분석
제5장 세계 gRNA 시장 - 제품 및 서비스별
- 주요 조사 결과
- 소개
- 제품
- 커스텀 gRNA 합성 서비스
제6장 세계 gRNA 시장 - gRNA 유형별
- 주요 조사 결과
- 소개
- 연구이용
- GMP 등급
제7장 세계 gRNA 시장 - 용도별
- 주요 조사 결과
- 소개
- 게놈 공학
- 질병 모델 연구
- 기능적 유전체학
- 후성 유전학
- 기타
제8장 세계 gRNA 시장 - 최종 용도별
- 주요 조사 결과
- 소개
- 제약 및 생명 공학 기업
- 학술연구기관
- CMO와 CRO
제9장 세계 gRNA 시장 - 지역별
- 주요 조사 결과
- 소개
- gRNA 시장 평가, 지역별(2019년-2032년)
- gRNA 시장-북미
- 북미 : gRNA 시장 - 제품 및 서비스별(2019년-2032년)
- 북미 : gRNA 시장 - 최종 용도별(2019년-2032년)
- 북미 : gRNA 시장 - gRNA 유형별(2019년-2032년)
- 북미 : gRNA 시장 - 용도별(2019년-2032년)
- gRNA 시장 - 미국
- gRNA 시장 - 캐나다
- gRNA 시장- 유럽
- 유럽 : gRNA 시장 - 제품 및 서비스별(2019년-2032년)
- 유럽: gRNA 시장 - 최종 용도별(2019년-2032년)
- 유럽 : gRNA 시장 - gRNA 유형별(2019년-2032년)
- 유럽 : gRNA 시장 - 용도별(2019년-2032년)
- gRNA 시장 - 영국
- gRNA 시장 - 프랑스
- gRNA 시장 - 독일
- gRNA 시장 - 이탈리아
- gRNA 시장 - 스페인
- gRNA 시장-네덜란드
- gRNA 시장 - 러시아
- gRNA 시장 - 아시아태평양
- 아시아태평양: gRNA 시장 - 제품 및 서비스별(2019년-2032년)
- 아시아태평양: gRNA 시장 - 최종 용도별(2019년-2032년)
- 아시아태평양: gRNA 시장 - gRNA 유형별(2019년-2032년)
- 아시아태평양: gRNA 시장 - 용도별(2019년-2032년)
- gRNA 시장- 중국
- gRNA 시장 - 인도
- gRNA 시장 - 일본
- gRNA 시장 - 말레이시아
- gRNA 시장 - 인도네시아
- gRNA 시장 - 한국
- gRNA 시장 - 중동 및 아프리카
- 중동 및 아프리카: gRNA 시장 - 제품 및 서비스별(2019년-2032년)
- 중동 및 아프리카: gRNA 시장 - 최종 용도별(2019년-2032년)
- 중동 및 아프리카 : gRNA 시장 - gRNA 유형별(2019년-2032년)
- 중동 및 아프리카 : gRNA 시장 - 용도별(2019년-2032년)
- gRNA 시장 - 사우디아라비아
- gRNA 시장 - 남아프리카
- gRNA 시장 - 이스라엘
- gRNA 시장 - 아랍에미리트(UAE)
- gRNA 시장 - 라틴아메리카
- 라틴아메리카: gRNA 시장 - 제품 및 서비스별(2019년-2032년)
- 라틴아메리카: gRNA 시장 - 최종 용도별(2019년-2032년)
- 라틴아메리카 : gRNA 시장 - gRNA 유형별(2019년-2032년)
- 라틴아메리카: gRNA 시장 - 용도별(2019년-2032년)
- gRNA 시장- 멕시코
- gRNA 시장 - 브라질
- gRNA 시장- 아르헨티나
제10장 경쟁 구도
- 확장 및 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제11장 기업 프로파일
- Agilent Technologies Inc.
- GENEWIZ(Azenta Life Sciences)
- Horizon Discovery Ltd.
- Jena Bioscience GmbH
- Merck KGaA
- Synbio Technologies
- Synthego
- System Biosciences, LLC.
- Takara Bio Inc.
- Thermo Fisher Scientific Inc
The global gRNA market size is expected to reach USD 2,357.17 million by 2032, according to a new study by Polaris Market Research. The report "gRNA Market Share, Size, Trends, Industry Analysis Report, By Product & Services (Products, Custom gRNA Synthesis Services), By gRNA Type, By Application, By End-use, By Region, And Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The market is poised for future growth, driven by the escalating investments from biotechnology and pharmaceutical companies in R&D activities. The creation of user-friendly and cost-effective gRNA synthesis kits and services has democratized access to CRISPR-Cas9 technology, catering to researchers across various expertise levels. The ongoing exploration of new applications for CRISPR-Cas9 contributes to the sustained demand for gRNA.
The increasing adoption of NGS is a significant catalyst for market growth. The widespread use of NGS technologies equips researchers with advanced tools for genomic analysis & manipulation. NGS enables the efficient sequencing of genetic material at high throughput, offering a rapid and cost-effective means of examining entire genomes. This efficiency is particularly crucial for gRNA applications, streamlining the identification and validation of target genes for genetic manipulation. This precision is essential in crafting gRNAs with high specificity using CRISPR/Cas systems.
Moreover, the introduction of new final gRNA products has the potential to stimulate innovation. For instance, in October 2023, Synthego, provider of IND-enabling gRNAs. This groundbreaking offering represents a significant progression in the CRISPR-based cell & gene therapy preclinical pipeline by furnishing researchers with meticulously designed, high-quality gRNAs tailored for GLP-regulated preclinical & IND-enabling studies.
Expanding the production volume may pose difficulties and could be constrained by the accessibility of suitable reagents, materials, and equipment. Irrespective of whether the therapy is autologous or allogeneic, a significant challenge lies in transitioning from manual processes to commercially automated manufacturing. This shift necessitates achieving uniformity throughout the entire process and ensuring compliance with regulations. For instance, the shortage of viral vectors in the capacity for cell and gene therapy is estimated to exceed 500%.
gRNA Market Report Highlights
The research use segment dominated the market, primarily due to ongoing clinical trials and molecular research purposes
The genomic engineering segment held the largest share due to advances in genomic and proteomics
Pharmaceutical companies garnered the largest share due to the adoption of gRNA in personalized therapies
Asia Pacific will grow rapidly, primarily due to presence of unmet medical needs and innovations in the sector
The market players include Agilent Technologies, Horizon Discovery, Jena Bioscience, Merck, Synbio Technologies, Synthego, & Takara Bio Inc.
Polaris Market Research has segmented the gRNA market report based on product and services, gRNA type, application, end use, and region:
gRNA, Product and Services Outlook (Revenue - USD Million, 2019 - 2032)
- Products
- gRNA Final Products
- gRNA Synthesis Products
- gRNA Synthesis Kits
- Plasmids
- Others
- Custom gRNA Synthesis Services
gRNA, Type Outlook (Revenue - USD Million, 2019 - 2032)
- Research-Use
- GMP-grade
gRNA, Application Outlook (Revenue - USD Million, 2019 - 2032)
- Genome Engineering
- Disease Model Studies
- Functional Genomics
- Epigenetics
- Others
gRNA, End Use Outlook (Revenue - USD Million, 2019 - 2032)
- Pharmaceutical & Biotechnology Companies
- Academic Research Institutes
- CMOs & CROs
gRNA, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global gRNA Market Insights
- 4.1. gRNA - Industry Snapshot
- 4.2. gRNA Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Innovations in proteomics and genomics
- 4.2.1.2. Rising necessity of personalized treatment
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Scalability and capacity shortage limiting growth
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. gRNA Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global gRNA Market, by Product & Services
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 5.3. Products
- 5.3.1. Global gRNA Market, by Products, by Region, 2019-2032 (USD Million)
- 5.3.2. gRNA Final Products
- 5.3.2.1. Global gRNA Market, by gRNA Final Products, by Region, 2019-2032 (USD Million)
- 5.3.3. gRNA Synthesis Products
- 5.3.3.1. Global gRNA Market, by gRNA Synthesis Products, by Region, 2019-2032 (USD Million)
- 5.3.3.2. gRNA Synthesis Kits
- 5.3.3.2.1. Global gRNA Market, by gRNA Synthesis Kits, by Region, 2019-2032 (USD Million)
- 5.3.3.3. Plasmids
- 5.3.3.3.1. Global gRNA Market, by Plasmids, by Region, 2019-2032 (USD Million)
- 5.3.3.4. Others
- 5.3.3.4.1. Global gRNA Market, by Others, by Region, 2019-2032 (USD Million)
- 5.4. Custom gRNA Synthesis Services
- 5.4.1. Global gRNA Market, by Custom gRNA Synthesis Services, by Region, 2019-2032 (USD Million)
6. Global gRNA Market, by gRNA Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 6.3. Research-Use
- 6.3.1. Global gRNA Market, by Research-Use, by Region, 2019-2032 (USD Million)
- 6.4. GMP-grade
- 6.4.1. Global gRNA Market, by GMP-grade, by Region, 2019-2032 (USD Million)
7. Global gRNA Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global gRNA Market, by Application, 2019-2032 (USD Million)
- 7.3. Genome Engineering
- 7.3.1. Global gRNA Market, by Genome Engineering, by Region, 2019-2032 (USD Million)
- 7.4. Disease Model Studies
- 7.4.1. Global gRNA Market, by Disease Model Studies, by Region, 2019-2032 (USD Million)
- 7.5. Functional Genomics
- 7.5.1. Global gRNA Market, by Functional Genomics, by Region, 2019-2032 (USD Million)
- 7.6. Epigenetics
- 7.6.1. Global gRNA Market, by Epigenetics, by Region, 2019-2032 (USD Million)
- 7.7. Others
- 7.7.1. Global gRNA Market, by Others, by Region, 2019-2032 (USD Million)
8. Global gRNA Market, by End-Use
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global gRNA Market, by End-Use, 2019-2032 (USD Million)
- 8.3. Pharmaceutical & Biotechnology Companies
- 8.3.1. Global gRNA Market, by Pharmaceutical & Biotechnology Companies, by Region, 2019-2032 (USD Million)
- 8.4. Academic Research Institutes
- 8.4.1. Global gRNA Market, by Academic Research Institutes, by Region, 2019-2032 (USD Million)
- 8.5. CMOs & CROs
- 8.5.1. Global gRNA Market, by CMOs & CROs, by Region, 2019-2032 (USD Million)
9. Global gRNA Market, by Geography
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. gRNA Market Assessment, By Geography, 2019-2032 (USD Million)
- 9.3. gRNA Market - North America
- 9.3.1. North America: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.3.2. North America: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.3.3. North America: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.3.4. North America: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.3.5. gRNA Market - U.S.
- 9.3.5.1. U.S.: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.3.5.2. U.S.: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.3.5.3. U.S.: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.3.5.4. U.S.: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.3.6. gRNA Market - Canada
- 9.3.6.1. Canada: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.3.6.2. Canada: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.3.6.3. Canada: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.3.6.4. Canada: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.4. gRNA Market - Europe
- 9.4.1. Europe: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.4.2. Europe: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.4.3. Europe: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.4.4. Europe: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.4.5. gRNA Market - UK
- 9.4.5.1. UK: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.4.5.2. UK: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.4.5.3. UK: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.4.5.4. UK: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.4.6. gRNA Market - France
- 9.4.6.1. France: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.4.6.2. France: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.4.6.3. France: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.4.6.4. France: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.4.7. gRNA Market - Germany
- 9.4.7.1. Germany: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.4.7.2. Germany: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.4.7.3. Germany: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.4.7.4. Germany: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.4.8. gRNA Market - Italy
- 9.4.8.1. Italy: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.4.8.2. Italy: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.4.8.3. Italy: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.4.8.4. Italy: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.4.9. gRNA Market - Spain
- 9.4.9.1. Spain: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.4.9.2. Spain: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.4.9.3. Spain: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.4.9.4. Spain: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.4.10. gRNA Market - Netherlands
- 9.4.10.1. Netherlands: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.4.10.2. Netherlands: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.4.10.3. Netherlands: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.4.10.4. Netherlands: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.4.11. gRNA Market - Russia
- 9.4.11.1. Russia: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.4.11.2. Russia.: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.4.11.3. Russia: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.4.11.4. Russia: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.5. gRNA Market - Asia Pacific
- 9.5.1. Asia Pacific: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.5.2. Asia Pacific: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.5.3. Asia Pacific: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.5.4. Asia Pacific: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.5.5. gRNA Market - China
- 9.5.5.1. China: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.5.5.2. China.: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.5.5.3. China: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.5.5.4. China: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.5.6. gRNA Market - India
- 9.5.6.1. India: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.5.6.2. India.: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.5.6.3. India: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.5.6.4. India: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.5.7. gRNA Market - Japan
- 9.5.7.1. Japan: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.5.7.2. Japan.: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.5.7.3. Japan: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.5.7.4. Japan: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.5.8. gRNA Market - Malaysia
- 9.5.8.1. Malaysia: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.5.8.2. Malaysia.: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.5.8.3. Malaysia: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.5.8.4. Malaysia: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.5.9. gRNA Market - Indonesia
- 9.5.9.1. Indonesia: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.5.9.2. Indonesia.: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.5.9.3. Indonesia: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.5.9.4. Indonesia: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.5.10. gRNA Market - South Korea
- 9.5.10.1. South Korea: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.5.10.2. South Korea.: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.5.10.3. South Korea: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.5.10.4. South Korea: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.6. gRNA Market - Middle East & Africa
- 9.6.1. Middle East & Africa: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.6.2. Middle East & Africa: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.6.3. Middle East & Africa: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.6.4. Middle East & Africa: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.6.5. gRNA Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.6.5.2. Saudi Arabia: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.6.5.3. Saudi Arabia: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.6.5.4. Saudi Arabia: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.6.6. gRNA Market - South Africa
- 9.6.6.1. South Africa: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.6.6.2. South Africa: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.6.6.3. South Africa: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.6.6.4. South Africa: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.6.7. gRNA Market - Israel
- 9.6.7.1. Israel: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.6.7.2. Israel: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.6.7.3. Israel: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.6.7.4. Israel: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.6.8. gRNA Market - UAE
- 9.6.8.1. UAE: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.6.8.2. UAE: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.6.8.3. UAE: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.6.8.4. UAE: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.7. gRNA Market - Latin America
- 9.7.1. Latin America: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.7.2. Latin America: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.7.3. Latin America: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.7.4. Latin America: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.7.5. gRNA Market - Mexico
- 9.7.5.1. Mexico: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.7.5.2. Mexico: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.7.5.3. Mexico: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.7.5.4. Mexico: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.7.6. gRNA Market - Brazil
- 9.7.6.1. Brazil: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.7.6.2. Brazil: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.7.6.3. Brazil: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.7.6.4. Brazil: gRNA Market, by Application, 2019-2032 (USD Million)
- 9.7.7. gRNA Market - Argentina
- 9.7.7.1. Argentina: gRNA Market, by Product & Services, 2019-2032 (USD Million)
- 9.7.7.2. Argentina: gRNA Market, by End-Use, 2019-2032 (USD Million)
- 9.7.7.3. Argentina: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
- 9.7.7.4. Argentina: gRNA Market, by Application, 2019-2032 (USD Million)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Agilent Technologies Inc.
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. GENEWIZ (Azenta Life Sciences)
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Horizon Discovery Ltd.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Jena Bioscience GmbH
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Merck KGaA
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Synbio Technologies
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Synthego
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. System Biosciences, LLC.
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Takara Bio Inc.
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Thermo Fisher Scientific Inc
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
